Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy
Crossref DOI link: https://doi.org/10.1007/s11060-017-2695-2
Published Online: 2017-12-02
Published Print: 2018-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Fang, Penny http://orcid.org/0000-0001-8172-5481
Boehling, Nicholas S.
Koay, Eugene J.
Bucheit, Amanda D.
Jakob, John A.
Settle, Stephen H.
Brown, Paul D.
Davies, Michael A.
Sulman, Erik P.
License valid from 2017-12-02